Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Breast Cancer Clinical Trials in Maryland | 900 Studies

Clinical Trials Breast CancerMaryland

Breast Cancer Clinical Trials in Maryland

Find 900 clinical trials for breast cancer near Maryland. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 501-520 of 900 trials

CompletedA Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast CancerThis study will evaluate the efficacy of ipatasertib + paclitaxel versus placebo + paclitaxel in participants with histologically confirmed, locally advanced or metastatic…NCT03337724·La Jolla, California and 175 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedRadiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone LumpectomyThis randomized phase III trial studies radiation therapy to see how well it works with or without trastuzumab in treating women with ductal carcinoma in situ who have undergone…NCT00769379·Anniston, Alabama and 1259 others

CompletedStudying Normal Breast Tissue and Cancer RiskBreast cancer is the most common cancer among women in the United States. Breast cancer research has been hampered by the difficulty in collecting normal breast tissue.NCT00341692·Bethesda, Maryland

CompletedOutcomes of Education and Counseling for BRCA1 TestingThis study will identify how personal beliefs, values and family experiences affect a person's decision as to whether or not to be tested for changes in a gene called BRCA1 or…NCT00001468·Bethesda, Maryland

CompletedStudy of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast CancerThe purpose of this study was to determine whether treatment with tamoxifen or a non-steroidal aromatase inhibitors (NSAI) + goserelin + LEE011 prolonged progression-free survival…NCT02278120·Bakersfield, California and 182 others

RecruitingFirst in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor MalignanciesThis is a first in human phase 1 study of AG01 an anti-Progranulin/Glycoprotein88 (PGRN/GP88) antibody in patients with advanced solid tumors.NCT05627960·Baltimore, Maryland

CompletedVaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian CancerRATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Interleukin-2 may stimulate a person's white blood cells to kill tumor cells.NCT00019916·Bethesda, Maryland and 1 other

Active not recruitingDoxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast CancerThis randomized phase III trial studies how well doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel with or without carboplatin work in treating patients with…NCT02488967·Mobile, Alabama and 1295 others

CompletedEarly Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast CancerRATIONALE: The primary tumor might be a source of re-seeding of distant sites and therefore elimination of this source of metastasizing cells by early local therapy may be of…NCT01242800·Mobile, Alabama and 376 others

CompletedStudy of DF1001 in Patients With Advanced Solid TumorsDF1001-001 is a study of a new molecule that targets natural killer (NK) cells and T-cell activation signals to specific receptors on cancer cells.NCT04143711·Irvine, California and 43 others

TerminatedEvaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In SituRATIONALE: The evaluation of breast cancer recurrence rates may improve the ability to plan cancer treatment for patients with breast cancer.NCT00002934·Atlanta, Georgia and 29 others

CompletedZoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal TherapyThis protocol is designed to compare the effect on bone of Zoledronic Acid 4 mg every 6 months when given upfront versus delayed start (based on a post-baseline BMD T- Score below…NCT00050011·Springdale, Arkansas and 43 others

CompletedA First in Human Study of BAY2701439 to Look at Safety, How the Body Absorbs, Distributes and Excretes the Drug, and How Well the Drug Works in Participants With Advanced Cancer Expressing the HER2 ProteinIn this study, researchers want to learn about the safety of drug BAY2701439 and how well the drug works in patients with advanced cancer that has the protein HER2 (Human…NCT04147819·Baltimore, Maryland and 5 others

RecruitingA Trial of AMXI-5001 for Treatment in Patients With Advanced MalignanciesATLAS-101 is a Phase I/II clinical trial of AMXI-5001 in adult participants with advanced malignancies who have previously failed other therapies. The study has two phases.NCT04503265·Los Angeles, California and 3 others

CompletedA Safety Study of SGN-LIV1A in Breast Cancer PatientsThis study will examine the safety and tolerability of ladiratuzumab vedotin (LV) in patients with metastatic breast cancer.NCT01969643·Birmingham, Alabama and 37 others

Active not recruitingPhase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can...Background: \- Durvalumab is a drug that may help people s immune systems respond to and kill cancer cells.NCT02484404·Bethesda, Maryland

RecruitingA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsThis is a proof-of-concept study designed to investigate HER3-DXd monotherapy in locally advanced unresectable or metastatic solid tumors.NCT06172478·Duarte, California and 95 others

Active not recruitingEntinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast CancerThis phase I trial studies the side effects and best dose of entinostat and nivolumab when given together with ipilimumab in treating patients with solid tumors that have spread…NCT02453620·Duarte, California and 4 others

CompletedStudy Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior TreatmentsThis was a Phase II, multicenter, open-label, three-cohort, non-comparative study of alpelisib plus endocrine therapy (either fulvestrant or letrozole) in subjects (pre- and…NCT03056755·Gilbert, Arizona and 93 others

TerminatedEfficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast CancerSTAGE 1: To determine the safety of enobosarm 9 milligram (mg) once daily (QD) used in combination with a CDK 4/6 inhibitor \[Verzenio® (abemaciclib) tablets, for oral use, 150 mg…NCT05065411·Chandler, Arizona and 29 others

PreviousPage 26 of 45Next

Other Conditions in Maryland

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma